A detailed history of Calamos Advisors LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Calamos Advisors LLC holds 38,642 shares of CLBT stock, worth $631,796. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,642
Previous 106,979 63.88%
Holding current value
$631,796
Previous $2.36 Million 68.17%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

SELL
$16.78 - $26.0 $1.15 Million - $1.78 Million
-68,337 Reduced 63.88%
38,642 $750,000
Q4 2024

Jan 24, 2025

BUY
$16.52 - $22.52 $1.17 Million - $1.6 Million
71,120 Added 198.33%
106,979 $2.36 Million
Q3 2024

Nov 07, 2024

BUY
$11.61 - $17.52 $416,322 - $628,249
35,859 New
35,859 $603,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.1B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.